These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 671212)

  • 21. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Albizia zygia gum as a binding agent in tablet formulations.
    Odeku OA
    Acta Pharm; 2005 Sep; 55(3):263-76. PubMed ID: 16375837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissolution of meprobamate from various tablet formulations.
    Hikal AH
    Pharmazie; 1983 Dec; 38(12):864-6. PubMed ID: 6669616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
    von Orelli J; Leuenberger H
    Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationship between configuration of starch grains in tablet and tablet disintegration (author's transl)].
    Nakai Y; Nakajima S
    Yakugaku Zasshi; 1977 Nov; 97(11):1168-73. PubMed ID: 616814
    [No Abstract]   [Full Text] [Related]  

  • 26. Physical properties and dissolution profiles of acetaminophen and acetylsalicyclic acid tablets made from sucrose-based vehicles.
    Elsabbagh HM; Ghanem AH; Elshaboury MH
    Pharmazie; 1981; 36(7):488-92. PubMed ID: 7280001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of marketed and formulated furosemide tablets.
    Elgindy NA; Ismail AA; Gadalla MA
    Pharmazie; 1981 Sep; 36(9):628-30. PubMed ID: 7301904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of water penetration on the disintegration of tablets with a starchy base].
    Couvreur P; Gillard J; Roland M
    Ann Pharm Fr; 1975 Dec; 33(12):683-92. PubMed ID: 1231613
    [No Abstract]   [Full Text] [Related]  

  • 30. [A method for comparison of the dissolution rates in sustained release tablets (author's transl)].
    Gimet R; Milhaud JC; Rabiant J
    J Pharm Belg; 1976; 31(1):89-100. PubMed ID: 1255407
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of hydrodynamic environment on tablet dissolution using flow-through dissolution apparatus.
    Wu Y; Ghaly ES
    P R Health Sci J; 2006 Mar; 25(1):75-83. PubMed ID: 16883682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disintegration and dissolution studies on amylobarbitone tablets.
    Surén G
    Acta Pharm Suec; 1970 Nov; 7(5):483-90. PubMed ID: 5488739
    [No Abstract]   [Full Text] [Related]  

  • 33. [A study by infrared spectroscopy of interactions between the time of disintegration of tablets and liberation of the active principal].
    Casahoursat L; Pham VH; Larrouture D; Heraud P; Etienne A
    Pharm Acta Helv; 1989; 64(8):225-30. PubMed ID: 2780756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of carboxymethyl starch as a tablet disintegrant.
    Mendell E
    Pharm Acta Helv; 1974; 49(7-8):248-50. PubMed ID: 4462126
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative evaluation using in vitro dissolution tests of various sustained release theophylline preparations].
    Kissné CE
    Acta Pharm Hung; 1990 Nov; 60(5-6):191-6. PubMed ID: 2087990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of swelling of disintegrants on tablet disintegration (author's transl)].
    Nakai Y; Nakajima S; Fukuoka E
    Yakugaku Zasshi; 1977 Oct; 97(10):1058-63. PubMed ID: 592097
    [No Abstract]   [Full Text] [Related]  

  • 37. [An interlaboratory cooperative study about pharmaceutical solids dissolution control (author's transl)].
    Jeannin C; Romier G; Verain A
    J Pharm Belg; 1979; 34(2):83-95. PubMed ID: 512823
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on an application of the complementary tristimulus colorimetry to the dissolution test of multi-ingredient tablet (author's transl)].
    Inagaki S; Katsuda H; Sumita K; Kitazawa S
    Yakugaku Zasshi; 1979 Apr; 99(4):329-34. PubMed ID: 480131
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of water of crystallization of berberine chloride on disintegration and dissolution behaviors of the tablet (author's transl)].
    Nakagawa H; Miyata T; Sugimoto I
    Yakugaku Zasshi; 1978 Nov; 98(10):1305-10. PubMed ID: 745037
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interactions between macromolecular adjuvants and drugs. Part 17: On the effect of macromolecular adjuvants on the dissolution rate of chlorpromazine from dosage forms (author's transl)].
    Voigt R; Gulde C; Sacher E
    Pharmazie; 1979; 34(3):168-71. PubMed ID: 450957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.